Navigation Links
Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease
Date:3/30/2011

About Nonalcoholic Steatohepatitis (NASH)

NASH is a more serious form of nonalcoholic fatty liver disease (NAFLD) and occurs in patients who drink little or no alcohol. NASH occurs most commonly in obese and insulin resistant patients, but is also seen in lean individuals. In a report of a 5-10 year follow-up study, up to 25% of NASH patients progressed to cirrhosis of the liver.  The prevalence of NASH in Japan is estimated to be at least 1% of the adult population and pediatric disease is also becoming more common, while in the US it is estimated that 3-5% of the population has the disease in association with higher obesity rates. There is currently no approved treatment for NASH.

About Intercept Pharmaceuticals, Inc.

Intercept is a biotechnology company focused on discovering and developing small molecule drugs for the treatment of chronic liver and metabolic diseases.  The company's most advanced programs are focused on the development of modified bile acids that are selective for FXR, a nuclear receptor, and TGR5, a G protein-coupled receptor. Bile acid signaling through these receptors regulates key aspects of lipid, glucose and overall energy metabolism, while also serving to maintain the functional integrity of the liver, intestine and kidneys, organs that are exposed to bile acid flux. For more information about Intercept, please go to www.interceptpharma.com. CONTACT: Mark Pruzanski, M.D. or Barbara Duncan, both of Intercept, +1-646-747-1000. For information about Intercept's majority shareholder Genextra S.p.A., please go to www.genextra.it.

About Dainippon Sumitomo Pharma Co., Ltd. (DSP)

DSP is a multi-billion dollar, top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical products. DSP aims to produce innovative pharmaceutical products in the central nervous system (CNS
'/>"/>

SOURCE Intercept Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma
2. Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia
3. Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
4. Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes
5. Isis Pharmaceuticals to Present at the 10th Annual Needham Healthcare Conference
6. Konica Minolta Sensing Announces CM-5 Spectrophotometer to Pharmaceutical Industry at Interphex 2011
7. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
8. SCOLR Pharma, Inc. Reports 2010 Financial Results, Provides Updates on Advances in Nutritionals, OTC Drugs
9. ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR)
10. New Survey Emphasizes Value of Biopharmaceutical Company Engagement With Healthcare Providers
11. LodgeNet Healthcare Partners With American Society of Health-System Pharmacists to Improve Clinical Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... -- , Safinamide significantly improves responder ... add-on to levodopa Safinamide is associated ... fluctuating PD patients as add-on to levodopa ... a research and development company focused on novel ... S.p.A., a pharmaceutical company strongly committed to the ...
(Date:6/18/2013)... June 18, 2013 Valeant Pharmaceuticals International, Inc. ... priced its previously announced public offering of common shares ... issue 23,529,412 common shares at a price of $85.00 ... billion. The Company will file a final prospectus supplement ... and will make a similar filing with the securities ...
(Date:6/18/2013)... ROCKY HILL, Conn. , June 18, 2013 ... many past clients of Alliance Seating and Mobility, ... now unable to access timely repair. This appears ... and a dramatic reduction of field service employees.  ... Unfortunately a great many of these clients ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4
... Calif., Aug. 31, 2011 Onyx Pharmaceuticals, ... it has appointed Helen Torley, M.B. Ch. B., M.R.C.P., ... her role, Dr. Torley will report to N. Anthony ... be responsible for all commercial activities related to Nexavar ...
... MOUNTAIN VIEW, Calif., Aug. 31, 2011 Concentric Medical, ... today announced that Stryker Corporation (NYSE: SYK ... Medical for $135 million in an all-cash transaction. The ... early in the fourth quarter of 2011. ...
Cached Medicine Technology:Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer 2Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer 3STRYKER Signs Definitive Agreement to Acquire CONCENTRIC MEDICAL, Inc. 2
(Date:6/19/2013)... 2013 North American Seminars combines ... course with an online continuing education course ... occupational therapists. , The two day ... an online continuing education course will ... solving skills needed to evaluate and treat dizziness ...
(Date:6/19/2013)... MA (PRWEB) June 19, 2013 ... collaboration and sensor machine software, today announced it ... for its Decentralized Fusion Engine technology. The ... and the acquisition of key strategic partnerships. ... and wireless collaboration and machine-to-machine (M2M) software products ...
(Date:6/19/2013)... Francisco, CA (PRWEB) June 19, 2013 The ... sized tents is because users can place a 4x8 flood ... clearance boundary space to work around. In addition, Gorilla ... tents. Because they are the tallest, thickest and strongest grow ... new bar for grow tent standards. , Gorilla ...
(Date:6/19/2013)... Tornadoes and their devastating aftermath have increased across the ... to these deadly storms find it hard to recover. ... and corporations from natural and man-made disasters for over ... philosophy of providing a storm shelter that can be ... stand up, with light and a battery-operated blower for ...
(Date:6/19/2013)... DC (PRWEB) June 19, 2013 ... in the history of managed care. As many ... coverage through the new state-based and federally operated ... for essential health benefits, and examples of premium ... states, industry-leading health business information publisher Atlantic Information ...
Breaking Medicine News(10 mins):Health News:New Evidence Based Information on Treatment for Over 8 Million People in the U.S. Affected With Disorders of the Vestibular System 2Health News:Blueforce Awarded Patent for Decentralized Sensor Fusion 2Health News:Stealth Grow Tent Brand’s Popularity Rises 2Health News:Radius Engineering International Inc. Tornado-Resistant Storm Shelters 2Health News:New Special Report Provides Comprehensive Overview of New Health Insurance Exchange Marketplaces 2
... could help many avoid stroke , , THURSDAY, Jan. 24 (HealthDay ... for preventing strokes was stopped early because of excess bleeding, ... researchers said the trial could open the way to at ... seems to occur primarily in two groups of people -- ...
... Preserve Competition in Three Clinical Testing,Markets, WASHINGTON, ... that it will require Pearson Plc to divest ... to proceed with,Pearson,s proposed $950 million acquisition of ... originally proposed, would have,resulted in higher prices to ...
... of,Health and Human Services (HHS) Secretary Mike ... developed by the Healthcare Information,Technology Standards Panel ... three,of its "Interoperability Specifications" to help support ... Nationwide Health Information Network in,the United States ...
... disease ulcerative colitis are at increased risk of developing ... colleagues at Kanazawa University, Japan, identified a central role ... colon cancer in mice in which inflammation of the ... by repeated dextran sulfate sodium (DSS) ingestion. Expression of ...
... The U.S. Department of,Labor today announced a $1,250,000 ... to help provide assistance in paying health insurance,premiums ... for the,Health Coverage Tax Credit. The assistance is ... of 2002., "This $1.25 million grant will ...
... SCOTTSDALE, Ariz., Jan. 24 DC Ranch Village ... literally. The latest yoga class,Chocolate-Covered Yoga, teaches yogis how ... but also how to heighten the senses, and experience,sensations ... eating., The class is a very fulfilling yoga ...
Cached Medicine News:Health News:Anti-Clotting Drug Trial Shortened by Bleeding Problems 2Health News:Justice Department Requires Divestitures in Pearson's Acquisition of Harcourt Assessment 2Health News:Justice Department Requires Divestitures in Pearson's Acquisition of Harcourt Assessment 3Health News:HHS Secretary Recognizes Products of HITSP Standards Work 2Health News:HHS Secretary Recognizes Products of HITSP Standards Work 3Health News:HHS Secretary Recognizes Products of HITSP Standards Work 4Health News:U.S. Department of Labor Announces $1.25 Million to North Carolina to Help Trade-Affected Workers Pay for Health Insurance 2Health News:DC Ranch Village Health Club & Spa Twists with Chocolate Yoga Class 2
The CALBIOTECH, INC. (CBI), Mumps IgM ELISA tests system is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Mumps in human serum or plasma....
The DSL-05-10-MUG Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgG-class antibodies to Mumps Virus in human serum. This assay is intended for in...
... Xact stent is self-expanding and has a closed-cell ... flexible mesh intended to help restore the inner ... inner vessel surface, and potentially reduce the release ... when it is treated, which can lead to ...
... With BareWire technology, the wire crosses the ... delivery catheter. All other actions, including filter ... placement then occur over the wire., ,Emboshield ... break off during a carotid stenting procedure, ...
Medicine Products: